Literature DB >> 32857249

MYB-NFIB Translocation by FISH in Adenoid Cystic Carcinoma of the Head and Neck in Nigerian Patients: A Preliminary Report.

Adepitan A Owosho1, Olufunlola M Adesina2, Oluwole Odujoko3, Olujide O Soyele2, Akinwumi Komolafe3, Robert Bauer4, Kallie Holte4, Kurt F Summersgill5.   

Abstract

Adenoid cystic carcinoma (AdCC) is a relatively rare malignancy of head and neck sites such as the salivary glands, lacrimal gland, sinonasal region, and pharynx and may arise in other exocrine glands. The oncologic event in AdCC is the translocation between MYB proto-oncogene transcription factor (MYB) and nuclear factor I/B (NFIB) resulting in t(6;9)(q22-23;p23-24). We carried out a preliminary evaluation of MYB-NFIB translocation by fluorescence in-situ hybridization on seven archived formalin-fixed paraffin-embedded tissues of AdCC of Nigerian patients and its clinicopathologic features. Only 3 of the 7 cases were successfully hybridized, all featuring MYB-NFIB translocations with a range of 14.7-83.3% of translocated cells in 60 cells examined. The 3 translocation positive cases were located in the maxillary sinus, buccal mucosa and parotid. Their morphologic appearances were cribriform-solid (1) & cribriform (2) and classified as grades III (1) & I (2), respectively. These patients may potentially benefit from MYB-targeted anti-neoplastic therapy.

Entities:  

Keywords:  Adenoid cystic carcinoma; MYB rearrangement; MYB-NFIB; Salivary gland tumors

Mesh:

Substances:

Year:  2020        PMID: 32857249      PMCID: PMC8134564          DOI: 10.1007/s12105-020-01214-3

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  29 in total

1.  Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality.

Authors:  J Fordice; C Kershaw; A El-Naggar; H Goepfert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-02

2.  Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.

Authors:  Lindsay Williams; Lester D R Thompson; Raja R Seethala; Ilan Weinreb; Adel M Assaad; Madalina Tuluc; Nasir Ud Din; Bibianna Purgina; Chi Lai; Christopher C Griffith; Simion I Chiosea
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

3.  Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.

Authors:  Bin Xu; Esther Drill; Allen Ho; Alan Ho; Lara Dunn; Carlos Nicolas Prieto-Granada; Timothy Chan; Ian Ganly; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2017-10       Impact factor: 6.394

4.  Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases.

Authors:  R H Spiro; A G Huvos; E W Strong
Journal:  Am J Surg       Date:  1974-10       Impact factor: 2.565

5.  Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.

Authors:  Marta Persson; Ywonne Andrén; Christopher A Moskaluk; Henry F Frierson; Susanna L Cooke; Philip Andrew Futreal; Teresia Kling; Sven Nelander; Anders Nordkvist; Fredrik Persson; Göran Stenman
Journal:  Genes Chromosomes Cancer       Date:  2012-04-16       Impact factor: 5.006

6.  MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.

Authors:  Robert B West; Christina Kong; Nicole Clarke; Thea Gilks; Joe S Lipsick; Hongbin Cao; Shirley Kwok; Kelli D Montgomery; Sushama Varma; Quynh-Thu Le
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

7.  Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion.

Authors:  Justin A Bishop; Ilan Weinreb; David Swanson; William H Westra; Hina S Qureshi; James Sciubba; Christina MacMillan; Lisa M Rooper; Brendan C Dickson
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

8.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

9.  Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.

Authors:  Ilan Weinreb; Lei Zhang; Laxmi M S Tirunagari; Yun-Shao Sung; Chun-Liang Chen; Bayardo Perez-Ordonez; Blaise A Clarke; Alena Skalova; Simion I Chiosea; Raja R Seethala; Daryl Waggott; Paul C Boutros; Christine How; Fei-Fei Liu; Jonathan C Irish; David P Goldstein; Ralph Gilbert; Nasir Ud Din; Adel Assaad; Jason L Hornick; Lester D R Thompson; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2014-06-18       Impact factor: 5.006

10.  Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.

Authors:  Alena Skálová; Tomas Vanecek; Emmanuelle Uro-Coste; Justin A Bishop; Ilan Weinreb; Lester D R Thompson; Stefano de Sanctis; Marco Schiavo-Lena; Jan Laco; Cécile Badoual; Thalita Santana Conceiçao; Nikola Ptáková; Martina Baněčkova; Marketa Miesbauerová; Michal Michal
Journal:  Am J Surg Pathol       Date:  2018-11       Impact factor: 6.394

View more
  2 in total

Review 1.  The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls.

Authors:  Kanwalpreet Kaur; Shailee Mehta; Sangita Vanik; Priti Trivedi; Nirmalya Banerjee; Harsh Dhar; Sourav Datta; Subhadeep Karanjai
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-10       Impact factor: 2.503

2.  HMGA2 Immunoexpression is frequent in salivary gland pleomorphic adenoma: immunohistochemical and molecular analyses of PLAG1 and HMGA2 in 25 cases.

Authors:  Adepitan A Owosho; Olufunlola M Adesina; Oluwole Odujoko; Hezekiah Akinyemi; Akinwumi Komolafe; Simon Tadros; Robert Bauer; Kurt F Summersgill
Journal:  Int J Clin Exp Pathol       Date:  2022-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.